These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 7728746

  • 1. Tumor regression in monoclonal antibody-treated patients correlates with the presence of anti-idiotype-reactive T lymphocytes.
    Fagerberg J, Hjelm AL, Ragnhammar P, Frödin JE, Wigzell H, Mellstedt H.
    Cancer Res; 1995 May 01; 55(9):1824-7. PubMed ID: 7728746
    [Abstract] [Full Text] [Related]

  • 2. Induction of an immune network cascade in cancer patients treated with monoclonal antibodies (ab1). II. Is induction of anti-idiotype reactive T cells (T3) of importance for tumor response to mAb therapy?
    Fagerberg J, Frödin JE, Ragnhammar P, Steinitz M, Wigzell H, Mellstedt H.
    Cancer Immunol Immunother; 1994 Mar 01; 38(3):149-59. PubMed ID: 8124683
    [Abstract] [Full Text] [Related]

  • 3. Induction of specific immunity to human colon carcinoma by anti-idiotypic antibodies to monoclonal antibody CO17-1A.
    Herlyn D, Ross AH, Iliopoulos D, Koprowski H.
    Eur J Immunol; 1987 Nov 01; 17(11):1649-52. PubMed ID: 3500066
    [Abstract] [Full Text] [Related]

  • 4. Clinical evidence that the human monoclonal anti-idiotypic antibody 105AD7, delays tumor growth by stimulating anti-tumor T-cell responses.
    Buckley DT, Robins AR, Durrant LG.
    Hum Antibodies Hybridomas; 1995 Nov 01; 6(2):68-72. PubMed ID: 7492753
    [Abstract] [Full Text] [Related]

  • 5. Clinical and immune responses in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen.
    Foon KA, John WJ, Chakraborty M, Sherratt A, Garrison J, Flett M, Bhattacharya-Chatterjee M.
    Clin Cancer Res; 1997 Aug 01; 3(8):1267-76. PubMed ID: 9815809
    [Abstract] [Full Text] [Related]

  • 6. Induction of an immune network cascade in cancer patients treated with monoclonal antibodies (ab1). I. May induction of ab1-reactive T cells and anti-anti-idiotypic antibodies (ab3) lead to tumor regression after mAb therapy?
    Fagerberg J, Frödin JE, Wigzell H, Mellstedt H.
    Cancer Immunol Immunother; 1993 Sep 01; 37(4):264-70. PubMed ID: 8348565
    [Abstract] [Full Text] [Related]

  • 7. The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A.
    Gruber R, van Haarlem LJ, Warnaar SO, Holz E, Riethmüller G.
    Cancer Res; 2000 Apr 01; 60(7):1921-6. PubMed ID: 10766181
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen.
    Foon KA, Oseroff AR, Vaickus L, Greenberg SJ, Russell D, Bernstein Z, Pincus S, Köhler H, Seon BK, Tahaoglu E.
    Clin Cancer Res; 1995 Nov 01; 1(11):1285-94. PubMed ID: 9815923
    [Abstract] [Full Text] [Related]

  • 10. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
    Wagner U, Köhler S, Prietl G, Giffels P, Schmidt-Nicolai S, Schlebusch H, Grünn U, Bender H, Biersack HJ, De Potter C, Krebs D, Wallwiener D.
    Zentralbl Gynakol; 1999 Nov 01; 121(4):190-5. PubMed ID: 10355096
    [Abstract] [Full Text] [Related]

  • 11. Anti-idiotype cancer vaccines: pre-clinical and clinical studies.
    Herlyn D, Benden A, Kane M, Somasundaram R, Zaloudik J, Sperlagh M, Marks G, Hart E, Ralph C, Wettendorff M.
    In Vivo; 1991 Nov 01; 5(6):615-23. PubMed ID: 1810448
    [Abstract] [Full Text] [Related]

  • 12. Induction of human breast cancer-specific antibody responses in cynomolgus monkeys by a murine monoclonal anti-idiotype antibody.
    Chakraborty M, Mukerjee S, Foon KA, Köhler H, Ceriani RL, Bhattacharya-Chatterjee M.
    Cancer Res; 1995 Apr 01; 55(7):1525-30. PubMed ID: 7533665
    [Abstract] [Full Text] [Related]

  • 13. Induction of antigen-specific T and B cell immunity in colon carcinoma patients by anti-idiotypic antibody.
    Somasundaram R, Zaloudik J, Jacob L, Benden A, Sperlagh M, Hart E, Marks G, Kane M, Mastrangelo M, Herlyn D.
    J Immunol; 1995 Sep 15; 155(6):3253-61. PubMed ID: 7673738
    [Abstract] [Full Text] [Related]

  • 14. Immunity to p53 induced by an idiotypic network of anti-p53 antibodies: generation of sequence-specific anti-DNA antibodies and protection from tumor metastasis.
    Erez-Alon N, Herkel J, Wolkowicz R, Ruiz PJ, Waisman A, Rotter V, Cohen IR.
    Cancer Res; 1998 Dec 01; 58(23):5447-52. PubMed ID: 9850078
    [Abstract] [Full Text] [Related]

  • 15. Immunotherapy of advanced ovarian carcinomas by activation of the idiotypic network.
    Wagner UA, Oehr PF, Reinsberg J, Schmidt SC, Schlebusch HW, Schultes B, Werner A, Prietl G, Krebs D.
    Biotechnol Ther; 1992 Dec 01; 3(1-2):81-9. PubMed ID: 1305894
    [Abstract] [Full Text] [Related]

  • 16. Human anti-idiotypic antibodies induced a humoral and cellular immune response against a colorectal carcinoma-associated antigen in patients.
    Fagerberg J, Steinitz M, Wigzell H, Askelöf P, Mellstedt H.
    Proc Natl Acad Sci U S A; 1995 May 23; 92(11):4773-7. PubMed ID: 7539133
    [Abstract] [Full Text] [Related]

  • 17. Immunotherapy for recurrent colorectal cancers with human monoclonal antibody SK-1.
    Koda K, Glassy MC, McKnight ME, Yasutomi J, Saito N, Dan M, Nakajima N.
    Anticancer Res; 2001 May 23; 21(1B):621-7. PubMed ID: 11299816
    [Abstract] [Full Text] [Related]

  • 18. Monoclonal anti-idiotype antibody bearing the internal image of nasopharyngeal carcinoma associated antigen.
    Li G, Hu J, Zhou G, Zhu J, Sun Q.
    Chin Med J (Engl); 2001 Sep 23; 114(9):962-6. PubMed ID: 11780392
    [Abstract] [Full Text] [Related]

  • 19. Immunopathology of metastases in patients of colorectal carcinoma treated with monoclonal antibody 17-1A and granulocyte macrophage colony-stimulating factor.
    Shetye J, Ragnhammar P, Liljefors M, Christensson B, Frödin JE, Biberfeld P, Mellstedt H.
    Clin Cancer Res; 1998 Aug 23; 4(8):1921-9. PubMed ID: 9717820
    [Abstract] [Full Text] [Related]

  • 20. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine.
    Maruyama H, Zaloudik J, Li W, Sperlagh M, Koido T, Somasundaram R, Scheck S, Prewett M, Herlyn D.
    Cancer Immunol Immunother; 2000 Jun 23; 49(3):123-32. PubMed ID: 10881691
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.